Achieve Life Sciences, Inc.ACHVNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-29.77M
↓ 42% below average
Average (9y)
$-20.90M
Historical baseline
Range
High:$-9.11M
Low:$-37.57M
CAGR
+13.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-29.77M | -21.5% |
| 2023 | $-24.50M | +34.8% |
| 2022 | $-37.57M | -27.6% |
| 2021 | $-29.44M | -118.2% |
| 2020 | $-13.49M | +11.6% |
| 2019 | $-15.27M | -43.1% |
| 2018 | $-10.67M | -17.2% |
| 2017 | $-9.11M | +69.4% |
| 2016 | $-29.73M | -213.9% |
| 2015 | $-9.47M | - |